Logo image of MDLY

Medley Management Inc (MDLY) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MDLY -

5.88
+0.1 (+1.73%)
Last: 7/6/2021, 8:04:00 PM
Fundamental Rating

1

MDLY gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 238 industry peers in the Capital Markets industry. MDLY has a bad profitability rating. Also its financial health evaluation is rather negative. MDLY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MDLY had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -7.49%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -14.15%
PM (TTM) -8.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

  • MDLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

  • MDLY has an Altman-Z score of -3.68. This is a bad value and indicates that MDLY is not financially healthy and even has some risk of bankruptcy.
  • MDLY has a Debt/Equity ratio of -0.97. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.97
Debt/FCF N/A
Altman-Z -3.68
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • MDLY has a Current Ratio of 0.14. This is a bad value and indicates that MDLY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.14 indicates that MDLY may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14

0

3. Growth

3.1 Past

  • MDLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.00%, which is quite impressive.
  • The Revenue for MDLY has decreased by -31.92% in the past year. This is quite bad
  • The Revenue for MDLY have been decreasing by -13.18% on average. This is quite bad
EPS 1Y (TTM)29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
Revenue 1Y (TTM)-31.92%
Revenue growth 3Y-20.04%
Revenue growth 5Y-13.18%
Sales Q2Q%-20.43%

3.2 Future

  • Based on estimates for the next years, MDLY will show a decrease in Earnings Per Share. The EPS will decrease by -3.61% on average per year.
  • The Revenue is expected to decrease by -31.10% on average over the next years. This is quite bad
EPS Next Y0%
EPS Next 2Y-3.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.41%
Revenue Next 2Y-31.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDLY Yearly Revenue VS EstimatesMDLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
MDLY Yearly EPS VS EstimatesMDLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 0 2 4 6

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MDLY. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDLY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDLY Price Earnings VS Forward Price EarningsMDLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -57.79
MDLY Per share dataMDLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150

4.3 Compensation for Growth

  • MDLY's earnings are expected to decrease with -3.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.61%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 11.90%, MDLY is a good candidate for dividend investing.
  • The stock price of MDLY dropped by -29.50% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • MDLY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 11.9%

5.2 History

  • The dividend of MDLY decreases each year by -34.93%.
  • MDLY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-34.93%
Div Incr YearsN/A
Div Non Decr YearsN/A
MDLY Yearly Dividends per shareMDLY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2 4 6

5.3 Sustainability

  • MDLY's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-3.61%
EPS Next 3YN/A

Medley Management Inc

NYSE:MDLY (7/6/2021, 8:04:00 PM)

5.88

+0.1 (+1.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners403.16%
Ins Owner Change0%
Market Cap3.94M
Revenue(TTM)33.25M
Net Income(TTM)-2.66M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 11.9%
Yearly Dividend0.7
Dividend Growth(5Y)-34.93%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -57.79
EPS(TTM)-4.26
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS49.63
BVpS-199.51
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -14.15%
PM (TTM) -8.01%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity -0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z -3.68
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.25%
EPS Next Y0%
EPS Next 2Y-3.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.92%
Revenue growth 3Y-20.04%
Revenue growth 5Y-13.18%
Sales Q2Q%-20.43%
Revenue Next Year-11.41%
Revenue Next 2Y-31.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Medley Management Inc / MDLY FAQ

What is the ChartMill fundamental rating of Medley Management Inc (MDLY) stock?

ChartMill assigns a fundamental rating of 1 / 10 to MDLY.


What is the valuation status for MDLY stock?

ChartMill assigns a valuation rating of 0 / 10 to Medley Management Inc (MDLY). This can be considered as Overvalued.


How profitable is Medley Management Inc (MDLY) stock?

Medley Management Inc (MDLY) has a profitability rating of 0 / 10.


What is the expected EPS growth for Medley Management Inc (MDLY) stock?

The Earnings per Share (EPS) of Medley Management Inc (MDLY) is expected to decline by 0% in the next year.